trans-(1S,2S)-N-[(7S,13S)-21-ethyl-20-[2-[(1S)-1-methoxyethyl]-5-(6-methyl-3,6-diazabicyclo[3.1.1]heptan-3-yl)-3-pyridinyl]-17,17-dimethyl-8,14-dioxo-15-oxa-4-thia-9,21,27,28-tetrazapentacyclo[17.5.2.12,5.19,13.022,26]octacosa-1(25),2,5(28),19,22(26),23-hexaen-7-yl]-2-methylcyclopropane-1-carboxamide

C45H58N8O5S — CID 164726597

IUPACtrans-(1S,2S)-N-[(7S,13S)-21-ethyl-20-[2-[(1S)-1-methoxyethyl]-5-(6-methyl-3,6-diazabicyclo[3.1.1]heptan-3-yl)-3-pyridinyl]-17,17-dimethyl-8,14-dioxo-15-oxa-4-thia-9,21,27,28-tetrazapentacyclo[17.5.2.12,5.19,13.022,26]octacosa-1(25),2,5(28),19,22(26),23-hexaen-7-yl]-2-methylcyclopropane-1-carboxamide
SMILESCCn1c(-c2cc(N3CC4CC(C3)N4C)cnc2[C@H](C)OC)c2c3cc(ccc31)-c1csc(n1)C[C@H](NC(=O)[C@H]1C[C@@H]1C)C(=O)N1CCC[C@H](N1)C(=O)OCC(C)(C)C2
InChIInChI=1S/C45H58N8O5S/c1-8-52-38-12-11-27-15-32(38)34(41(52)33-17-28(20-46-40(33)26(3)57-7)51-21-29-16-30(22-51)50(29)6)19-45(4,5)24-58-44(56)35-10-9-13-53(49-35)43(55)36(18-39-47-37(27)23-59-39)48-42(54)31-14-25(31)2/h11-12,15,17,20,23,25-26,29-31,35-36,49H,8-10,13-14,16,18-19,21-22,24H2,1-7H3,(H,48,54)/t25-,26-,29?,30?,31-,35-,36-/m0/s1
InChIKeyWCGITDLDGCDHDO-XAUKFXTCSA-N
MW823.08 g/mol
LogP5.75
Rot. Bonds7

About trans-(1S,2S)-N-[(7S,13S)-21-ethyl-20-[2-[(1S)-1-methoxyethyl]-5-(6-methyl-3,6-diazabicyclo[3.1.1]heptan-3-yl)-3-pyridinyl]-17,17-dimethyl-8,14-dioxo-15-oxa-4-thia-9,21,27,28-tetrazapentacyclo[17.5.2.12,5.19,13.022,26]octacosa-1(25),2,5(28),19,22(26),23-hexaen-7-yl]-2-methylcyclopropane-1-carboxamide

trans-(1S,2S)-N-[(7S,13S)-21-ethyl-20-[2-[(1S)-1-methoxyethyl]-5-(6-methyl-3,6-diazabicyclo[3.1.1]heptan-3-yl)-3-pyridinyl]-17,17-dimethyl-8,14-dioxo-15-oxa-4-thia-9,21,27,28-tetrazapentacyclo[17.5.2.12,5.19,13.022,26]octacosa-1(25),2,5(28),19,22(26),23-hexaen-7-yl]-2-methylcyclopropane-1-carboxamide (PubChem CID 164726597) has the molecular formula C45H58N8O5S and a molecular weight of 823.08 g/mol. Its IUPAC name is trans-(1S,2S)-N-[(7S,13S)-21-ethyl-20-[2-[(1S)-1-methoxyethyl]-5-(6-methyl-3,6-diazabicyclo[3.1.1]heptan-3-yl)-3-pyridinyl]-17,17-dimethyl-8,14-dioxo-15-oxa-4-thia-9,21,27,28-tetrazapentacyclo[17.5.2.12,5.19,13.022,26]octacosa-1(25),2,5(28),19,22(26),23-hexaen-7-yl]-2-methylcyclopropane-1-carboxamide.

Molecular Properties

Compound Nametrans-(1S,2S)-N-[(7S,13S)-21-ethyl-20-[2-[(1S)-1-methoxyethyl]-5-(6-methyl-3,6-diazabicyclo[3.1.1]heptan-3-yl)-3-pyridinyl]-17,17-dimethyl-8,14-dioxo-15-oxa-4-thia-9,21,27,28-tetrazapentacyclo[17.5.2.12,5.19,13.022,26]octacosa-1(25),2,5(28),19,22(26),23-hexaen-7-yl]-2-methylcyclopropane-1-carboxamide
PubChem CID164726597
Molecular FormulaC45H58N8O5S
Molecular Weight823.08 g/mol
Exact Mass822.43
IUPAC Nametrans-(1S,2S)-N-[(7S,13S)-21-ethyl-20-[2-[(1S)-1-methoxyethyl]-5-(6-methyl-3,6-diazabicyclo[3.1.1]heptan-3-yl)-3-pyridinyl]-17,17-dimethyl-8,14-dioxo-15-oxa-4-thia-9,21,27,28-tetrazapentacyclo[17.5.2.12,5.19,13.022,26]octacosa-1(25),2,5(28),19,22(26),23-hexaen-7-yl]-2-methylcyclopropane-1-carboxamide
SMILESCCn1c(-c2cc(N3CC4CC(C3)N4C)cnc2[C@H](C)OC)c2c3cc(ccc31)-c1csc(n1)C[C@H](NC(=O)[C@H]1C[C@@H]1C)C(=O)N1CCC[C@H](N1)C(=O)OCC(C)(C)C2
InChIInChI=1S/C45H58N8O5S/c1-8-52-38-12-11-27-15-32(38)34(41(52)33-17-28(20-46-40(33)26(3)57-7)51-21-29-16-30(22-51)50(29)6)19-45(4,5)24-58-44(56)35-10-9-13-53(49-35)43(55)36(18-39-47-37(27)23-59-39)48-42(54)31-14-25(31)2/h11-12,15,17,20,23,25-26,29-31,35-36,49H,8-10,13-14,16,18-19,21-22,24H2,1-7H3,(H,48,54)/t25-,26-,29?,30?,31-,35-,36-/m0/s1
InChIKeyWCGITDLDGCDHDO-XAUKFXTCSA-N
XLogP5.75
TPSA134.16 Ų
H-Bond Donors2
H-Bond Acceptors12
Rotatable Bonds7
Heavy Atoms59
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500823.08
LogP ≤ 55.75
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1012

Analyze trans-(1S,2S)-N-[(7S,13S)-21-ethyl-20-[2-[(1S)-1-methoxyethyl]-5-(6-methyl-3,6-diazabicyclo[3.1.1]heptan-3-yl)-3-pyridinyl]-17,17-dimethyl-8,14-dioxo-15-oxa-4-thia-9,21,27,28-tetrazapentacyclo[17.5.2.12,5.19,13.022,26]octacosa-1(25),2,5(28),19,22(26),23-hexaen-7-yl]-2-methylcyclopropane-1-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of trans-(1S,2S)-N-[(7S,13S)-21-ethyl-20-[2-[(1S)-1-methoxyethyl]-5-(6-methyl-3,6-diazabicyclo[3.1.1]heptan-3-yl)-3-pyridinyl]-17,17-dimethyl-8,14-dioxo-15-oxa-4-thia-9,21,27,28-tetrazapentacyclo[17.5.2.12,5.19,13.022,26]octacosa-1(25),2,5(28),19,22(26),23-hexaen-7-yl]-2-methylcyclopropane-1-carboxamide?
The IUPAC name of trans-(1S,2S)-N-[(7S,13S)-21-ethyl-20-[2-[(1S)-1-methoxyethyl]-5-(6-methyl-3,6-diazabicyclo[3.1.1]heptan-3-yl)-3-pyridinyl]-17,17-dimethyl-8,14-dioxo-15-oxa-4-thia-9,21,27,28-tetrazapentacyclo[17.5.2.12,5.19,13.022,26]octacosa-1(25),2,5(28),19,22(26),23-hexaen-7-yl]-2-methylcyclopropane-1-carboxamide (CID 164726597) is trans-(1S,2S)-N-[(7S,13S)-21-ethyl-20-[2-[(1S)-1-methoxyethyl]-5-(6-methyl-3,6-diazabicyclo[3.1.1]heptan-3-yl)-3-pyridinyl]-17,17-dimethyl-8,14-dioxo-15-oxa-4-thia-9,21,27,28-tetrazapentacyclo[17.5.2.12,5.19,13.022,26]octacosa-1(25),2,5(28),19,22(26),23-hexaen-7-yl]-2-methylcyclopropane-1-carboxamide.
What is the SMILES notation for trans-(1S,2S)-N-[(7S,13S)-21-ethyl-20-[2-[(1S)-1-methoxyethyl]-5-(6-methyl-3,6-diazabicyclo[3.1.1]heptan-3-yl)-3-pyridinyl]-17,17-dimethyl-8,14-dioxo-15-oxa-4-thia-9,21,27,28-tetrazapentacyclo[17.5.2.12,5.19,13.022,26]octacosa-1(25),2,5(28),19,22(26),23-hexaen-7-yl]-2-methylcyclopropane-1-carboxamide?
The canonical SMILES for trans-(1S,2S)-N-[(7S,13S)-21-ethyl-20-[2-[(1S)-1-methoxyethyl]-5-(6-methyl-3,6-diazabicyclo[3.1.1]heptan-3-yl)-3-pyridinyl]-17,17-dimethyl-8,14-dioxo-15-oxa-4-thia-9,21,27,28-tetrazapentacyclo[17.5.2.12,5.19,13.022,26]octacosa-1(25),2,5(28),19,22(26),23-hexaen-7-yl]-2-methylcyclopropane-1-carboxamide is CCn1c(-c2cc(N3CC4CC(C3)N4C)cnc2[C@H](C)OC)c2c3cc(ccc31)-c1csc(n1)C[C@H](NC(=O)[C@H]1C[C@@H]1C)C(=O)N1CCC[C@H](N1)C(=O)OCC(C)(C)C2.
What is the InChIKey of trans-(1S,2S)-N-[(7S,13S)-21-ethyl-20-[2-[(1S)-1-methoxyethyl]-5-(6-methyl-3,6-diazabicyclo[3.1.1]heptan-3-yl)-3-pyridinyl]-17,17-dimethyl-8,14-dioxo-15-oxa-4-thia-9,21,27,28-tetrazapentacyclo[17.5.2.12,5.19,13.022,26]octacosa-1(25),2,5(28),19,22(26),23-hexaen-7-yl]-2-methylcyclopropane-1-carboxamide?
The InChIKey is WCGITDLDGCDHDO-XAUKFXTCSA-N. The full InChI is InChI=1S/C45H58N8O5S/c1-8-52-38-12-11-27-15-32(38)34(41(52)33-17-28(20-46-40(33)26(3)57-7)51-21-29-16-30(22-51)50(29)6)19-45(4,5)24-58-44(56)35-10-9-13-53(49-35)43(55)36(18-39-47-37(27)23-59-39)48-42(54)31-14-25(31)2/h11-12,15,17,20,23,25-26,29-31,35-36,49H,8-10,13-14,16,18-19,21-22,24H2,1-7H3,(H,48,54)/t25-,26-,29?,30?,31-,35-,36-/m0/s1.
What are the key properties of trans-(1S,2S)-N-[(7S,13S)-21-ethyl-20-[2-[(1S)-1-methoxyethyl]-5-(6-methyl-3,6-diazabicyclo[3.1.1]heptan-3-yl)-3-pyridinyl]-17,17-dimethyl-8,14-dioxo-15-oxa-4-thia-9,21,27,28-tetrazapentacyclo[17.5.2.12,5.19,13.022,26]octacosa-1(25),2,5(28),19,22(26),23-hexaen-7-yl]-2-methylcyclopropane-1-carboxamide?
trans-(1S,2S)-N-[(7S,13S)-21-ethyl-20-[2-[(1S)-1-methoxyethyl]-5-(6-methyl-3,6-diazabicyclo[3.1.1]heptan-3-yl)-3-pyridinyl]-17,17-dimethyl-8,14-dioxo-15-oxa-4-thia-9,21,27,28-tetrazapentacyclo[17.5.2.12,5.19,13.022,26]octacosa-1(25),2,5(28),19,22(26),23-hexaen-7-yl]-2-methylcyclopropane-1-carboxamide has a molecular weight of 823.08 g/mol, XLogP of 5.75, 7 rotatable bonds, 2 hydrogen bond donors, and 12 hydrogen bond acceptors.
Where does this data come from?
All data for trans-(1S,2S)-N-[(7S,13S)-21-ethyl-20-[2-[(1S)-1-methoxyethyl]-5-(6-methyl-3,6-diazabicyclo[3.1.1]heptan-3-yl)-3-pyridinyl]-17,17-dimethyl-8,14-dioxo-15-oxa-4-thia-9,21,27,28-tetrazapentacyclo[17.5.2.12,5.19,13.022,26]octacosa-1(25),2,5(28),19,22(26),23-hexaen-7-yl]-2-methylcyclopropane-1-carboxamide is sourced from PubChem (CID 164726597), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).